Centiva Capital’s Mereo BioPharma MREO Stock Holding History

Centiva Capital’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.94K	Hold	25,000	–	–	﹤0.01%	1753
2026 Q1	$8.25K	Hold	25,000	–	–	﹤0.01%	1584
2025 Q4	$10.4K	Hold	25,000	–	–	﹤0.01%	1237
2025 Q3	$51.5K	Hold	25,000	–	–	﹤0.01%	946
2025 Q2	$67.8K	Hold	25,000	–	–	﹤0.01%	1419
2025 Q1	$56.3K	Hold	25,000	–	–	﹤0.01%	1433
2024 Q4	$87.5K	Hold	25,000	–	–	﹤0.01%	1505
2024 Q3	$103K	Hold	25,000	–	–	﹤0.01%	1957
2024 Q2	$90K	Hold	25,000	–	–	﹤0.01%	1869
2024 Q1	$82.5K	Hold	25,000	–	–	﹤0.01%	1626
2023 Q4	$57.8K	Hold	25,000	–	–	﹤0.01%	1636
2023 Q3	$32.3K	Hold	25,000	–	–	﹤0.01%	1624
2023 Q2	$33K	Hold	25,000	–	–	﹤0.01%	1526
2023 Q1	$17.8K	Hold	25,000	–	–	﹤0.01%	1435
2022 Q4	$18.8K	Hold	25,000	–	–	﹤0.01%	1285
2022 Q3	$22K	Hold	25,000	–	–	﹤0.01%	1381
2022 Q2	$28K	Buy	+25,000	New	+$19.4K	﹤0.01%	1493

Other funds holding MREO

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Centiva Capital's MREO Position: Q2 2026 in Review

Centiva Capital held its Mereo BioPharma (MREO) position steady in Q2 2026 at 25,000 shares worth $7.94K. The position accounts for ﹤0.01% of the portfolio, ranked #1753.

Centiva Capital first reported a position in MREO in Q2 2022 and has held it in 17 quarters since. The position peaked at $103K in Q3 2024. 61 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

Centiva Capital held 25,000 shares of Mereo BioPharma worth $7.94K as of Q2 2026.
Centiva Capital left its Mereo BioPharma share count unchanged in Q2 2026.
Mereo BioPharma made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1753 holding.
Centiva Capital first reported a position in Mereo BioPharma in Q2 2022 and has held it in 17 quarters since.
Centiva Capital's Mereo BioPharma position peaked at $103K in Q3 2024.
61 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.